http://www.unboundmedicine.com/medline/ebm/research/efavirenzUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19926964/full_citation/Efficacy_and_safety_of_TMC278_in_antiretroviral_naive_HIV_1_patients:_week_96_results_of_a_phase_IIb_randomized_trial_Pozniak AL, Morales-Ramirez J, Katabira E, et al. 
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial. [JOURNAL ARTICLE]
AIDS 2009 Nov 18.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19925403/full_citation/Long_Term_Effectiveness_and_Safety_Outcomes_in_HIV_1_Infected_Patients_After_a_Median_Time_of_6_Years_on_Nevirapine_Rodríguez-Arrondo F, Aguirrebengoa K, Portu J, et al. 
Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine. [JOURNAL ARTICLE]
Curr HIV Res 2009 Sep; 7(5):526-532.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19922061/full_citation/Treatment_of_HIV_infection:_Swedish_recommendations_2009_Josephson F, Albert J, Flamholc L, et al. 
Treatment of HIV infection: Swedish recommendations 2009. [JOURNAL ARTICLE]
Scand J Infect Dis 2009; 41(11-12):788-807.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19918107/full_citation/Progress_in_basic_and_clinical_research_on_HIV_resistance:_report_on_the_XVIII_International_HIV_Drug_Resistance_Workshop_Mascolini M, Boucher CA, Mellors JW, et al. 
Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. [Journal Article]
Antivir Ther 2009; 14(7):1015-37.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19916993/full_citation/A_novel_polymorphism_in_ABCB1_gene_CYP2B6_6_and_sex_predict_single_dose_efavirenz_population_pharmacokinetics_in_Ugandans_Mukonzo JK, Röshammar D, Waako P, et al. 
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans. [Journal Article, Research Support, Non-U.S. Gov't]
Br J Clin Pharmacol 2009 Nov; 68(5):690-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19911963/full_citation/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_Hoffmann CJ, Charalambous S, Sim J, et al. 
Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19909170/full_citation/Reversal_of_Growth_Failure_in_HIV_Infected_Thai_Children_Treated_with_Non_Nucleoside_Reverse_Transcriptase_Inhibitor_Based_Antiretroviral_Therapy_Aurpibul L, Puthanakit T, Taecharoenkul S, et al. 
Reversal of Growth Failure in HIV-Infected Thai Children Treated with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. [JOURNAL ARTICLE]
AIDS Patient Care STDS 2009 Nov 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19906624/full_citation/Viral_Load_Decay_in_Antiretroviral_Naïve_Patients_Receiving_Once_Daily_Tenofovir_and_Emtricitabine_plus_Twice_Daily_Nevirapine_Amoroso A, Gilliam BL, Talwani R, et al. 
Viral Load Decay in Antiretroviral-Naïve Patients Receiving Once-Daily Tenofovir and Emtricitabine plus Twice-Daily Nevirapine. [Journal Article]
HIV Clin Trials 2009 Sep-Oct; 10(5):320-3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_Marseille E, Kahn JG, Pitter C, et al. 
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. [Journal Article]
Appl Health Econ Health Policy 2009; 7(4):229-43.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19897506/full_citation/Factors_influencing_lopinavir_and_atazanavir_plasma_concentration_Stöhr W, Back D, Dunn D, et al. 
Factors influencing lopinavir and atazanavir plasma concentration. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Nov 6.
Abstract | Full Citation